Back to Journals » OncoTargets and Therapy » Volume 12
Case report
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,009 | Dovepress* | 4,566+ | 766 | 5,332 | |
PubMed Central* | 443 | 132 | 575 | ||
Totals | 5,009 | 898 | 5,907 | ||
*Since 29 May 2019 |
View citations on PubMed Central and Google Scholar